1-2 of 2
Joel S. Parker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti–PD-1 Therapy

Dante S. Bortone, Mark G. Woodcock, Joel S. Parker, Benjamin G. Vincent
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (1): 103–112.
https://doi.org/10.1158/2326-6066.CIR-20-0398
Published: 04 January 2021
View article titled, Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti–PD-1 Therapy
Open the PDF for Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti–PD-1 Therapy in another window
Includes: Supplementary data
Journal Articles

Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes

Christof C. Smith, Shengjie Chai, Amber R. Washington, Samuel J. Lee, Elisa Landoni, Kevin Field, Jason Garness, Lisa M. Bixby, Sara R. Selitsky, Joel S. Parker, Barbara Savoldo, Jonathan S. Serody, Benjamin G. Vincent
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2019) 7 (10): 1591–1604.
https://doi.org/10.1158/2326-6066.CIR-19-0155
Published: 01 October 2019
View article titled, Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes
Open the PDF for Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes in another window
Includes: Supplementary data